Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Net Income | 93.82% | -55.11% | -12.45% | 25.15% | 62.55% |
| Total Depreciation and Amortization | -- | -200.00% | -64.39% | 246.91% | -30.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.94% | -200.00% | 110.02% | -2,313.17% | -94.61% |
| Change in Net Operating Assets | -- | 200.00% | -101.68% | 943.85% | 7.59% |
| Cash from Operations | 100.39% | -267.71% | -126.57% | 692.07% | -339.85% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -200.00% | 20.12% | 0.94% | -- |
| Total Debt Repaid | -- | 200.00% | 26.08% | -89.69% | -48.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | -- |
| Cash from Financing | -219.93% | 402.29% | 114.53% | -48.44% | 366.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 19,754.55% | -- | -- | -- | -- |
| Net Change in Cash | -179.25% | 205.15% | -187.77% | 295.79% | 211.76% |